APA

Keitel W. A., Kester K. E., Atmar R. L., White A. C., Bond N. H., Holland C. A., Krzych U., Palmer D. R., Egan A., Diggs C., Ballou W. R., Hall B. F. & Kaslow D. (20000113). Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. : Vaccine.

Chicago

Keitel W A, Kester K E, Atmar R L, White A C, Bond N H, Holland C A, Krzych U, Palmer D R, Egan A, Diggs C, Ballou W R, Hall B F and Kaslow D. 20000113. Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. : Vaccine.

Harvard

Keitel W. A., Kester K. E., Atmar R. L., White A. C., Bond N. H., Holland C. A., Krzych U., Palmer D. R., Egan A., Diggs C., Ballou W. R., Hall B. F. and Kaslow D. (20000113). Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. : Vaccine.

MLA

Keitel W A, Kester K E, Atmar R L, White A C, Bond N H, Holland C A, Krzych U, Palmer D R, Egan A, Diggs C, Ballou W R, Hall B F and Kaslow D. Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. : Vaccine. 20000113.